ZURA: Zura Bio Limited Growth-Adjusted Market Cap to Net Income
The growth stock attractiveness indicator on the GURU.Markets aggregate chart is fixed at 0.00. The success of Zura Bio Limited (ZURA) relies on successful clinical trials and sufficient capital. The company is scaling its portfolio through partnerships with biolabs, implementing asset synergy. Future profits are based on the supply of innovative antibodies to insurance companies treating autoimmune pathologies.
Metric breakdowns and analytics for Zura Bio (ZURA)
- share price and consensus valuation forecast:
- market capitalization information:
- company book value details:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
ZURA - Company Net Income|Expected Net Income Zura Bio Limited|ZURA - P/E Multiple|Forward P/E Multiple zurabio.com|ZURA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Zura Bio Limited|ZURA - Operating profit EBITDA|Earnings per share for the last twelve months Zura Bio|ZURA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months zurabio.com|ZURA - Earnings per share growth in current year|Expected net earnings per share growth next year Zura Bio Limited
General company analysis:ZURA - zurabio.com
For Zura Bio Limited (ZURA), which is developing innovative antibodies in an active R&D phase, the current PEG ratio serves as an indicator of the market's valuation of future profit potential. The metric is calculated by dividing the P/E ratio by the earnings growth rate; a value below one signals that the asset is undervalued relative to its expansion, which is critical when analyzing high-risk biotechnology companies.
Who Zura Bio Limited competes with
ARGX (argenx N.V.) - Growth-Adjusted Payback Ratio|PEG Multiple BNTX (BioNTech Group)|Growth-Adjusted Market Cap to Net Income Abivax (ABVX)|ADMA - Price/Earnings to Growth Ratio|protagonist-inc.com (PTGX) - Price/Earnings to Growth Multiple|Immunovant (IMVT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Kiniksa Pharmaceuticals, Ltd.|Price/Earnings to Growth Multiple GRFS|PEG Multiple Adaptive Biotechnologies Inc.|Price/Earnings to Growth Ratio Celldex Therapeutics (CLDX)|auriniapharma.com - Growth-Adjusted P/E Ratio|PEG Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Price to Earnings Adjusted for Growth Rate|DNTH: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio PHVS|ABCL (abcellera.com) - Price/Earnings to Growth Multiple|tourmalinebio.com (TRML) - PEG Multiple|Price/Earnings to Growth Ratio Precigen|PHAR: Growth-Adjusted Payback Ratio|PEG Multiple NKTR|PEG Multiple Upstream Pharma (UPB)|Zenas Biopharma Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio IMNM|Gossamer Bio - PEG Multiple|KALV: Price/Earnings to Growth Ratio|SEPN: PEG Multiple|PVLA - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Savara Inc.|Price to Earnings Adjusted for Growth Rate rigel.com RIGL|Price/Earnings to Growth Multiple ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio enGene Bio ENGN|rapt.com - Price/Earnings to Growth Ratio|Aerovate - PEG Multiple|Growth-Adjusted Market Cap to Net Income aclaristx.com ACRS|Kyverna Therapeutics, Inc. (KYTX) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - PEG Multiple|Ventyx Biosciences, Inc (VTYX) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple THTX (Theratechnologies Inc.)|Company Value to Earnings Growth Ratio AVTX|PEG Multiple ELDN (Eledon Pharmaceuticals, Inc.)|Agenus, Inc. (AGEN) - Price to Earnings Adjusted for Growth Rate|Climb Bio, Inc. - PEG Multiple|ATYR (aTyr Pharmaceuticals) - Growth-Adjusted P/E Ratio|ADAG (adagene.com) - Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio IMA (Ikena Oncology)|Price/Earnings to Growth Multiple STTK|PEG Multiple Equillium Bio|Price/Earnings to Growth Ratio Connect Biopharma (CNTB)|IMUX (immunic-therapeutics.com) - Growth-Adjusted Payback Ratio|PEG Multiple ATRA (Atara Bio)|PEG Multiple InflaRx NV IFRX|XFOR - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio ACET|CELU: PEG Multiple|INmune Bio Corporation - Growth-Adjusted Payback Ratio|BRNS (Barinthus Biotherapeutics) - PEG Multiple|PEG Multiple kezarlifesciences.com|Price/Earnings to Growth Ratio SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics PLC) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enlivex Therapeutics Ltd. ENLV|QTTB - Price/Earnings to Growth Multiple|GeoVax Labs, Inc. - PEG Multiple|EDSA - PEG Multiple|IBIO (iBio) - Price/Earnings to Growth Multiple|Carisma Therapeutics Inc. - Growth-Adjusted Payback Ratio|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG Multiple|Bolt Bio (BOLT) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio HCW Biologics Inc. (HCWB)|Price/Earnings to Growth Multiple aptevotherapeutics.com APVO|Price/Earnings to Growth Ratio AIM ImmunoTech AIM|ADTX - Price/Earnings to Growth Multiple|GRI: Price/Earnings to Growth Multiple|XRTX - PEG Multiple|Vyome Holdings Inc (HIND) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio REVB|INDP (Indaptus Therapeutics, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Scinai Immunotherapeutics Ltd SCNI|Price/Earnings to Growth Multiple CALI (CalciMedica, Inc.)|AFMD: Market Cap to Earnings and Growth Ratio|Allakos - Price/Earnings to Growth Multiple|PEG Multiple HOOKIPA Pharma, Inc. HOOK|IGMS - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio ITOS (iTeos Therapeutics Inc)|OCEA: PEG Multiple|TC BioPharm Ltd (TCBP) - PEG Multiple|Price/Earnings to Growth Multiple THRD
